18-methyl-19-nor-androst-4-en-17,17-s piroether (18-methyl-19-nor-20spirox4-en-3-one) and pharmaceutical preparations containing the same

Details for Australian Patent Application No. 2007263944 (hide)

Owner Bayer Schering Pharma Aktiengesellschaft

Inventors Muhn, Hans-Peter; Gallus, Norbert; Prelle, Katja; Menges, Frederik; Bohlmann, Rolf; Borden, Steffen; Hubner, Jan; Kuhnke, Joachim

Agent Davies Collison Cave

Pub. Number AU-A-2007263944

PCT Pub. Number WO2008/000521

Priority 10 2006 030 416.0 29.06.06 DE

Filing date 29 June 2007

Wipo publication date 3 January 2008

International Classifications

C07J 53/00 (2006.01) Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by condensation with carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms

A61K 31/58 (2006.01) - containing heterocyclic rings, e.g. aldosterone, danazol, stanozolol, pancuronium, digitogenin

A61P 5/34 (2006.01) Drugs for disorders of the endocrine system

A61P 5/42 (2006.01) Drugs for disorders of the endocrine system

Event Publications

29 January 2009 PCT application entered the National Phase

  PCT publication WO2008/000521 Priority application(s): WO2008/000521

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007263981-Rabeprazole formulation

2007263939-Improved sgp130Fc dimers